Mycophenolate mofetil
Articles · Medicine Compliance Aid Stability · Lactation Safety Information · Published , updated
109131004
Articles
20th December 2018
Which medicines require extra care when switching between liquid and tablet/capsule formulations?
For a small number of medicines, there are differences in equivalent doses of oral formulations of the same medicine. This Q&A considers which medicines may… Alfacalcidol Carbamazepine Chloral hydrate Citalopram Clomethiazole Clozapine Co-amoxiclav Digoxin Emtricitabine Fusidic acid Itraconazole Lithium Mebeverine Medicine Medicines Safety Mercaptopurine Metronidazole Mycophenolate mofetil Mycophenolic acid Phenytoin Phenytoin sodium Posaconazole Q&A Raltegravir Selegiline Sirolimus Tenofovir Tipranavir Valproic acid Vardenafil
13th July 2018
What injections can be given enterally?
This updated Medicines Q&A is a quick reference summary to different types of enteral feeding tubes, in relation to medication issues. Not all enteral feeding… Acetazolamide Acetylcysteine Aminophylline Arginine Atropine Benzatropine Calcium folinate Chlorphenamine Clonazepam Clonidine Cyclizine Cyclophosphamide Desferrioxamine Dexamethasone Diazepam Digoxin Dinoprostone Dipyridamole Disopyramide Flecainide Glycopyrronium Hydralazine Hydrocortisone Hyoscine butylbromide Hyoscine hydrobromide Ketamine Labetalol Levomepromazine Medicines Safety Medroxyprogesterone Methotrexate Methylprednisolone sodium succinate Metoclopramide Metoprolol Midazolam Mycophenolate mofetil Ondansetron Pentazocine Pethidine Pharmaceutical Stability Phytomenadione Procainamide Procyclidine Propranolol Q&A Ranitidine Sodium bicarbonate Sodium chloride Sodium phenylbutyrate Tranexamic acid Vancomycin Verapamil
8th December 2017
Suggestions for Therapeutic Drug Monitoring in Adults in Primary Care
This document is intended to support local discussions on how to monitor commonly prescribed high risk medicines in primary care. Comments have been included as… Acute Care Aminophylline Amiodarone Apixaban Aripiprazole Atorvastatin Azathioprine Candesartan Carbimazole Care homes Celecoxib Ciclosporin Community Health Services Dabigatran etexilate Diclofenac potassium Diclofenac sodium Digoxin Donepezil Dronedarone Edoxaban Enalapril Eplerenone Etoricoxib Galantamine Haloperidol Hydrocortisone Hydroxycarbamide Ibuprofen Leflunomide Levothyroxine Lisinopril Lithium Losartan Mental Health Mercaptopurine Mesalazine Methotrexate Mycophenolate mofetil Mycophenolic acid Naproxen News Nitrofurantoin Olanzapine Penicillamine Perindopril Phenytoin Phenytoin sodium Pioglitazone Pravastatin Prednisolone Primary Care Propylthiouracil Quetiapine Ramipril Risperidone Rivaroxaban Rivastigmine Rosuvastatin Simvastatin Sirolimus Sodium valproate Spironolactone Sulfasalazine Tacrolimus Telmisartan Theophylline Transfer of care Valproic acid WarfarinMedicine Compliance Aid Stability
CellCept · Roche Products Ltd
Roche Products Ltd
CellCept
Tablets 500mg
R2 · Red 2 · Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Protect from light. Protect from moisture. Airtight container. Teratogenic.
8th October 2015
CellCept · Roche Products Ltd
Roche Products Ltd
CellCept
Capsules 250mg
R2 · Red 2 · Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Store in original package to protect from moisture.
8th October 2015
Lactation Safety Information
See summary
Avoid in preterm and newborn infants
No published evidence of safety